Interestingly, aggressive subtypes of cancer and chronic renal failure are associated with the systemic induction of lipocalin-2 (Lcn2) [6], coding for a protein recently discovered to be involved in the regulation of appetite [7] and recently demonstrated by our group to play a critical role in appetite suppression during pancreatic cancer cachexia [8]. Here, LCN2 is linked to chronic kidney disease.